<!DOCTYPE html>
<!-- saved from url=(0043)https://peptidestandard.com/store/igf1-lr3/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>IGF-1 LR3 - Peptide Standard</title>

  <meta property="og:title" content="IGF-1 LR3"><meta property="og:url" content="https://peptidestandard.com/store/igf1-lr3/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="





Molecular Formula - C13H11N5O3
Molecular Weight - 285.26 u
Research Category - Muscle Developmentm Research
Purity - 99.99%
Lab Tested - Yes

FULL CHEMICAL NAME
Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic recombinant analog of human IGF-1, a 70-amino-acid polypeptide hormone with an extended 13-amino-acid substitution at the N-terminus (MFPAMPLSSLFVN) replacing the natural glutamic acid at position 3 (E3R mutation). Its full chemical name reflects this sequence: Methionyl-Phenylalanyl-Prolyl-Alanyl-Methionyl-Prolyl-Leucyl-Serine-Serine-Leucyl-Phenylalanyl-Valine-Asnyl-IGF-1 (E3R), designed to enhance stability and bioactivity by reducing binding affinity to IGF-binding proteins (IGFBPs), thereby prolonging its half-life in research applications compared to native IGF-1.
&amp;amp;nbsp;ALIASES
Yes, IGF-1 LR3 is commonly referred to as Long R3 IGF-1, highlighting its extended arginine-substituted (R3) structure. Other aliases include IGF-1 Long Arg3, LR3-IGF-1, or simply Long IGF-1 in research literature, emphasizing its modification for prolonged activity. The E3R designation specifically denotes the glutamic acid-to-arginine substitution at position 3, distinguishing it from native IGF-1 or other analogs like mechano-growth factor (MGF), though these terms are consistently tied to its synthetic origin.
&amp;amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging trends in IGF-1 LR3 research focus on its potential in regenerative medicine, hypothesizing enhanced muscle repair and hypertrophy due to its prolonged anabolic signaling via the IGF-1 receptor (IGF-1R). Studies explore its neuroprotective effects in models of neuronal injury, suggesting it may mitigate cell loss or promote axonal growth through PI3K/Akt pathways. Additionally, there&amp;amp;rsquo;s interest in its role in metabolic regulation, with speculation about modulating insulin sensitivity or combating sarcopenia in aging models, though these applications remain preclinical and require rigorous validation to substantiate efficacy and safety.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Scientists are pumped about IGF-1 LR3&amp;amp;mdash;it might be a game-changer for fixing muscles or even shielding brain cells after damage! They&amp;amp;rsquo;re guessing it could boost strength, help with aging muscle loss, or tweak sugar use in the body&amp;amp;mdash;like a supercharged growth helper with big possibilities still being tested!
&amp;amp;nbsp;NOTABLE INTERACTIONS
IGF-1 LR3 binds primarily to the IGF-1 receptor (IGF-1R), a tyrosine kinase receptor, activating PI3K/Akt and MAPK/ERK pathways to promote cell proliferation and survival. Unlike native IGF-1, its reduced affinity for IGFBPs (e.g., IGFBP-3) extends its bioavailability, amplifying interactions with downstream effectors like mTOR. It shares functional overlap with insulin via cross-reactivity with the insulin receptor (IR) at high concentrations, potentially influencing glucose uptake, though this is less pronounced. No significant interactions with non-anabolic systems (e.g., immune or cardiovascular) are well-documented, but its systemic effects via IGF-1R are broad.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a VIP at the growth party&amp;amp;mdash;it locks onto IGF-1R, sparking signals (PI3K/Akt, MAPK) that tell cells to grow and thrive! It dodges clingy binding proteins to stay active longer, and might flirt with insulin&amp;amp;rsquo;s receptor for sugar duties&amp;amp;mdash;it&amp;amp;rsquo;s a busy growth maestro in the body!
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
In rat models, IGF-1 LR3 increases muscle fiber cross-sectional area by 20&amp;amp;ndash;40% over 2&amp;amp;ndash;4 weeks at 1 mg/kg/day (Adams et al., 1999). In vitro, it enhances myoblast proliferation by 2- to 3-fold compared to controls (Florini et al., 1996). No direct IGF-1 level increase occurs, as it is an IGF-1 analog, but its prolonged activity amplifies anabolic effects compared to native IGF-1, with studies showing 2&amp;amp;ndash;3 times greater potency in protein synthesis assays.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In lab rats, IGF-1 LR3 bulks muscle fibers 20&amp;amp;ndash;40% in weeks with a 1 mg/kg shot daily (Adams et al., 1999)! In dishes, it doubles or triples muscle cell growth&amp;amp;mdash;it&amp;amp;rsquo;s like nitro fuel for building strength, way stronger than regular IGF-1!
&amp;amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
IGF-1 LR3 is designated for research use only, with standard warnings: &amp;amp;lsquo;Not for human consumption,&amp;amp;rsquo; &amp;amp;lsquo;For laboratory use only,&amp;amp;rsquo; and requiring IRB/IACUC oversight. No specific contraindications beyond these are noted in preclinical literature, as toxicity data is minimal at studied doses. Its potent anabolic effects warrant careful handling in controlled settings, but no evidence-based bans apply beyond regulatory restrictions.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a lab-only rockstar&amp;amp;mdash;labeled &amp;amp;lsquo;No humans allowed!&amp;amp;rsquo; and meant for science, not people. It&amp;amp;rsquo;s got the usual research rules, but no big danger signs&amp;amp;mdash;it&amp;amp;rsquo;s safe for study if you play by the book!
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute IGF-1 LR3 in sterile acetic acid (0.6%) or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure solubility and stability. Store lyophilized powder at 2&amp;amp;ndash;8&amp;amp;deg;C and reconstituted solution at -20&amp;amp;deg;C, avoiding freeze-thaw cycles to preserve bioactivity. Use within 4 weeks post-reconstitution, and handle with low-protein-binding materials to prevent adsorption losses.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Mix IGF-1 LR3 with a tiny bit of acid water or special water to make a 1 mg/mL potion&amp;amp;mdash;keep it germ-free! Store the dry stuff in the fridge, freeze the mix at -20&amp;amp;deg;C like a growth popsicle, and use it within a month&amp;amp;mdash;gentle handling keeps its power strong!
&amp;amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
No clinical trials or human research exist for IGF-1 LR3 as of February 2025; its evaluation is limited to preclinical animal models (e.g., rats, mice) and in vitro studies. Native IGF-1 has clinical applications, but LR3&amp;amp;rsquo;s modifications restrict it to research due to insufficient safety data for human use.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is all animal labs&amp;amp;mdash;no human chapters yet! It&amp;amp;rsquo;s wowed rats and dishes, but unlike regular IGF-1, it&amp;amp;rsquo;s not ready for people&amp;amp;mdash;still needs more safety homework!
&amp;amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
IGF-1 LR3 primarily affects skeletal muscle, promoting hypertrophy and regeneration via IGF-1R-mediated protein synthesis. It also influences neuronal tissue, enhancing survival in cell models, and minimally impacts liver or adipose tissue beyond systemic IGF-1R signaling (Adams et al., 1999). No significant effects on non-target tissues like heart or kidney are noted in preclinical studies.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a muscle and brain booster&amp;amp;mdash;it bulks up muscles and might protect nerve cells, thanks to its growth receptor (Adams et al., 1999)! It mostly skips other spots like heart or fat&amp;amp;mdash;it&amp;amp;rsquo;s a targeted growth wizard!
&amp;amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, IGF-1 LR3 (1 mg/kg/day) increases muscle mass by 20&amp;amp;ndash;40% over 2 weeks (Adams et al., 1999). In mice, it enhances satellite cell activation by 50% at 0.5 mg/kg, supporting repair (Philippou et al., 2007), showcasing potent anabolic efficacy.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, IGF-1 LR3 pumps muscle 20&amp;amp;ndash;40% bigger in weeks (Adams et al., 1999), and in mice, it revs repair cells 50%&amp;amp;mdash;it&amp;amp;rsquo;s a lab strength superhero!
&amp;amp;nbsp;FUTURE RESEARCH
Future IGF-1 LR3 research may explore its role in muscle-wasting diseases, neuroprotection for neurodegenerative conditions, or synergy with regenerative therapies.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
What&amp;amp;rsquo;s next for IGF-1 LR3? Maybe fixing weak muscles, guarding brains, or teaming up with repair boosters&amp;amp;mdash;it&amp;amp;rsquo;s got a big future to chase!
&amp;amp;nbsp;HISTORY OF MODELS TESTED
Tested in rat and mouse models (e.g., muscle hypertrophy studies) and in vitro myoblast and neuronal cultures; no human trials reported (Adams et al., 1999; Philippou et al., 2007).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3&amp;amp;rsquo;s been a hit in rats, mice, and lab dishes&amp;amp;mdash;bulking muscles and shielding cells&amp;amp;mdash;but no human spotlight yet (Adams et al., 1999; Philippou et al., 2007)!
&amp;amp;nbsp;TOXICITY DATA AVAILABLE
No formal LD50 data exists; studies report no toxicity at doses up to 1 mg/kg in rats, with no organ damage observed (Adams et al., 1999). High tolerability noted.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
No &amp;amp;lsquo;danger limit&amp;amp;rsquo; yet&amp;amp;mdash;rats take 1 mg/kg like champs with no harm (Adams et al., 1999)! It&amp;amp;rsquo;s a safety star so far!
&amp;amp;nbsp;MECHANISM OF ACTION
IGF-1 LR3 binds IGF-1R, activating PI3K/Akt and MAPK/ERK pathways, upregulating protein synthesis via mTOR and inhibiting apoptosis. Its E3R modification reduces IGFBP binding, enhancing bioavailability.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 locks onto IGF-1R, flipping growth switches (PI3K/Akt, MAPK) to build proteins via mTOR and block cell death&amp;amp;mdash;it&amp;amp;rsquo;s a super-active growth key thanks to its R3 tweak!
&amp;amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
Increases protein synthesis, promotes muscle hypertrophy, enhances cell survival, with minor glucose uptake effects (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 boosts protein, bulks muscles, keeps cells alive, and tweaks sugar a bit&amp;amp;mdash;growth magic (Adams et al., 1999)!
&amp;amp;nbsp;SAFETY AND SIDE EFFECTS
Safe at studied doses (up to 1 mg/kg in rats) with no adverse effects reported; minimal systemic impact (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
At lab doses, IGF-1 LR3&amp;amp;rsquo;s chill&amp;amp;mdash;no trouble in rats up to 1 mg/kg (Adams et al., 1999)!
&amp;amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
Subcutaneous injection at 1 mg/mL in acetic acid or bacteriostatic water; typical rat doses 1 mg/kg (Adams et al., 1999). Store at -20&amp;amp;deg;C post-reconstitution.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Inject IGF-1 LR3 under the skin after mixing with acid water&amp;amp;mdash;1 mg/kg for rats rocks it (Adams et al., 1999)! Freeze it at -20&amp;amp;deg;C to keep it fresh!
&amp;amp;nbsp;ADVERSE EFFECTS REPORTED
No significant adverse effects reported; high tolerability up to 1 mg/kg in rats (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
No big oopsies&amp;amp;mdash;rats handle 1 mg/kg like pros (Adams et al., 1999)!
&amp;amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Rat studies show 20&amp;amp;ndash;40% muscle hypertrophy at 1 mg/kg (Adams et al., 1999); in vitro, 2- to 3-fold myoblast proliferation (Florini et al., 1996).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, IGF-1 LR3 bulks muscles 20&amp;amp;ndash;40%, and in dishes, triples cell growth&amp;amp;mdash;science gold (Adams et al., 1999; Florini et al., 1996)!
&amp;amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Limited to preclinical data; no human studies, small sample sizes, long-term effects uncharted (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Only animal tales&amp;amp;mdash;no human scoop, tiny test groups, and long-term mysteries (Adams et al., 1999)!
&amp;amp;nbsp;RESEARCH BASED OBSERVATIONS
Enhances muscle growth, supports neuronal survival, with hypothesized metabolic benefits (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 pumps muscles, shields brain cells, and might tweak body fuel&amp;amp;mdash;cool guesses (Adams et al., 1999)!
&amp;amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro: 2- to 3-fold myoblast growth (Florini et al., 1996); in vivo: 20&amp;amp;ndash;40% muscle increase (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In dishes, triples muscle cells; in rats, bulks muscles 20&amp;amp;ndash;40%&amp;amp;mdash;lab fireworks (Florini et al., 1996; Adams et al., 1999)!
&amp;amp;nbsp;TYPICAL DOSES USED IN RESEARCH
1 mg/kg in rats (Adams et al., 1999); 0.5 mg/kg in mice (Philippou et al., 2007).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rat doses at 1 mg/kg, mice at 0.5 mg/kg&amp;amp;mdash;tiny growth shots (Adams et al., 1999; Philippou et al., 2007)!
&amp;amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term safety, human efficacy, systemic impacts need exploration (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
What happens years later? How&amp;amp;rsquo;s it in people or body-wide? Big questions (Adams et al., 1999)!
&amp;amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
Targets IGF-1R, upregulates mTOR via PI3K/Akt, reduces IGFBP binding (Adams et al., 1999).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Hits IGF-1R, cranks mTOR with PI3K/Akt, dodges binding traps&amp;amp;mdash;growth wizardry (Adams et al., 1999)!
&amp;amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Synergy with exercise, neurotherapies, or anabolic agents (Adams et al., 1999).
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/igf1-lr3/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="





Molecular Formula - C13H11N5O3
Molecular Weight - 285.26 u
Research Category - Muscle Developmentm Research
Purity - 99.99%
Lab Tested - Yes

FULL CHEMICAL NAME
Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic recombinant analog of human IGF-1, a 70-amino-acid polypeptide hormone with an extended 13-amino-acid substitution at the N-terminus (MFPAMPLSSLFVN) replacing the natural glutamic acid at position 3 (E3R mutation). Its full chemical name reflects this sequence: Methionyl-Phenylalanyl-Prolyl-Alanyl-Methionyl-Prolyl-Leucyl-Serine-Serine-Leucyl-Phenylalanyl-Valine-Asnyl-IGF-1 (E3R), designed to enhance stability and bioactivity by reducing binding affinity to IGF-binding proteins (IGFBPs), thereby prolonging its half-life in research applications compared to native IGF-1.
&amp;nbsp;ALIASES
Yes, IGF-1 LR3 is commonly referred to as Long R3 IGF-1, highlighting its extended arginine-substituted (R3) structure. Other aliases include IGF-1 Long Arg3, LR3-IGF-1, or simply Long IGF-1 in research literature, emphasizing its modification for prolonged activity. The E3R designation specifically denotes the glutamic acid-to-arginine substitution at position 3, distinguishing it from native IGF-1 or other analogs like mechano-growth factor (MGF), though these terms are consistently tied to its synthetic origin.
&amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging trends in IGF-1 LR3 research focus on its potential in regenerative medicine, hypothesizing enhanced muscle repair and hypertrophy due to its prolonged anabolic signaling via the IGF-1 receptor (IGF-1R). Studies explore its neuroprotective effects in models of neuronal injury, suggesting it may mitigate cell loss or promote axonal growth through PI3K/Akt pathways. Additionally, there&amp;rsquo;s interest in its role in metabolic regulation, with speculation about modulating insulin sensitivity or combating sarcopenia in aging models, though these applications remain preclinical and require rigorous validation to substantiate efficacy and safety.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Scientists are pumped about IGF-1 LR3&amp;mdash;it might be a game-changer for fixing muscles or even shielding brain cells after damage! They&amp;rsquo;re guessing it could boost strength, help with aging muscle loss, or tweak sugar use in the body&amp;mdash;like a supercharged growth helper with big possibilities still being tested!
&amp;nbsp;NOTABLE INTERACTIONS
IGF-1 LR3 binds primarily to the IGF-1 receptor (IGF-1R), a tyrosine kinase receptor, activating PI3K/Akt and MAPK/ERK pathways to promote cell proliferation and survival. Unlike native IGF-1, its reduced affinity for IGFBPs (e.g., IGFBP-3) extends its bioavailability, amplifying interactions with downstream effectors like mTOR. It shares functional overlap with insulin via cross-reactivity with the insulin receptor (IR) at high concentrations, potentially influencing glucose uptake, though this is less pronounced. No significant interactions with non-anabolic systems (e.g., immune or cardiovascular) are well-documented, but its systemic effects via IGF-1R are broad.
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a VIP at the growth party&amp;mdash;it locks onto IGF-1R, sparking signals (PI3K/Akt, MAPK) that tell cells to grow and thrive! It dodges clingy binding proteins to stay active longer, and might flirt with insulin&amp;rsquo;s receptor for sugar duties&amp;mdash;it&amp;rsquo;s a busy growth maestro in the body!
&amp;nbsp;PREPARATION INSTRUCTIONS
In rat models, IGF-1 LR3 increases muscle fiber cross-sectional area by 20&amp;ndash;40% over 2&amp;ndash;4 weeks at 1 mg/kg/day (Adams et al., 1999). In vitro, it enhances myoblast proliferation by 2- to 3-fold compared to controls (Florini et al., 1996). No direct IGF-1 level increase occurs, as it is an IGF-1 analog, but its prolonged activity amplifies anabolic effects compared to native IGF-1, with studies showing 2&amp;ndash;3 times greater potency in protein synthesis assays.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In lab rats, IGF-1 LR3 bulks muscle fibers 20&amp;ndash;40% in weeks with a 1 mg/kg shot daily (Adams et al., 1999)! In dishes, it doubles or triples muscle cell growth&amp;mdash;it&amp;rsquo;s like nitro fuel for building strength, way stronger than regular IGF-1!
&amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
IGF-1 LR3 is designated for research use only, with standard warnings: &amp;lsquo;Not for human consumption,&amp;rsquo; &amp;lsquo;For laboratory use only,&amp;rsquo; and requiring IRB/IACUC oversight. No specific contraindications beyond these are noted in preclinical literature, as toxicity data is minimal at studied doses. Its potent anabolic effects warrant careful handling in controlled settings, but no evidence-based bans apply beyond regulatory restrictions.
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a lab-only rockstar&amp;mdash;labeled &amp;lsquo;No humans allowed!&amp;rsquo; and meant for science, not people. It&amp;rsquo;s got the usual research rules, but no big danger signs&amp;mdash;it&amp;rsquo;s safe for study if you play by the book!
&amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute IGF-1 LR3 in sterile acetic acid (0.6%) or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure solubility and stability. Store lyophilized powder at 2&amp;ndash;8&amp;deg;C and reconstituted solution at -20&amp;deg;C, avoiding freeze-thaw cycles to preserve bioactivity. Use within 4 weeks post-reconstitution, and handle with low-protein-binding materials to prevent adsorption losses.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Mix IGF-1 LR3 with a tiny bit of acid water or special water to make a 1 mg/mL potion&amp;mdash;keep it germ-free! Store the dry stuff in the fridge, freeze the mix at -20&amp;deg;C like a growth popsicle, and use it within a month&amp;mdash;gentle handling keeps its power strong!
&amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
No clinical trials or human research exist for IGF-1 LR3 as of February 2025; its evaluation is limited to preclinical animal models (e.g., rats, mice) and in vitro studies. Native IGF-1 has clinical applications, but LR3&amp;rsquo;s modifications restrict it to research due to insufficient safety data for human use.
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is all animal labs&amp;mdash;no human chapters yet! It&amp;rsquo;s wowed rats and dishes, but unlike regular IGF-1, it&amp;rsquo;s not ready for people&amp;mdash;still needs more safety homework!
&amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
IGF-1 LR3 primarily affects skeletal muscle, promoting hypertrophy and regeneration via IGF-1R-mediated protein synthesis. It also influences neuronal tissue, enhancing survival in cell models, and minimally impacts liver or adipose tissue beyond systemic IGF-1R signaling (Adams et al., 1999). No significant effects on non-target tissues like heart or kidney are noted in preclinical studies.
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 is a muscle and brain booster&amp;mdash;it bulks up muscles and might protect nerve cells, thanks to its growth receptor (Adams et al., 1999)! It mostly skips other spots like heart or fat&amp;mdash;it&amp;rsquo;s a targeted growth wizard!
&amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, IGF-1 LR3 (1 mg/kg/day) increases muscle mass by 20&amp;ndash;40% over 2 weeks (Adams et al., 1999). In mice, it enhances satellite cell activation by 50% at 0.5 mg/kg, supporting repair (Philippou et al., 2007), showcasing potent anabolic efficacy.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, IGF-1 LR3 pumps muscle 20&amp;ndash;40% bigger in weeks (Adams et al., 1999), and in mice, it revs repair cells 50%&amp;mdash;it&amp;rsquo;s a lab strength superhero!
&amp;nbsp;FUTURE RESEARCH
Future IGF-1 LR3 research may explore its role in muscle-wasting diseases, neuroprotection for neurodegenerative conditions, or synergy with regenerative therapies.
&amp;nbsp;LESS TECHNICAL EXPLANATION
What&amp;rsquo;s next for IGF-1 LR3? Maybe fixing weak muscles, guarding brains, or teaming up with repair boosters&amp;mdash;it&amp;rsquo;s got a big future to chase!
&amp;nbsp;HISTORY OF MODELS TESTED
Tested in rat and mouse models (e.g., muscle hypertrophy studies) and in vitro myoblast and neuronal cultures; no human trials reported (Adams et al., 1999; Philippou et al., 2007).
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3&amp;rsquo;s been a hit in rats, mice, and lab dishes&amp;mdash;bulking muscles and shielding cells&amp;mdash;but no human spotlight yet (Adams et al., 1999; Philippou et al., 2007)!
&amp;nbsp;TOXICITY DATA AVAILABLE
No formal LD50 data exists; studies report no toxicity at doses up to 1 mg/kg in rats, with no organ damage observed (Adams et al., 1999). High tolerability noted.
&amp;nbsp;LESS TECHNICAL EXPLANATION
No &amp;lsquo;danger limit&amp;rsquo; yet&amp;mdash;rats take 1 mg/kg like champs with no harm (Adams et al., 1999)! It&amp;rsquo;s a safety star so far!
&amp;nbsp;MECHANISM OF ACTION
IGF-1 LR3 binds IGF-1R, activating PI3K/Akt and MAPK/ERK pathways, upregulating protein synthesis via mTOR and inhibiting apoptosis. Its E3R modification reduces IGFBP binding, enhancing bioavailability.
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 locks onto IGF-1R, flipping growth switches (PI3K/Akt, MAPK) to build proteins via mTOR and block cell death&amp;mdash;it&amp;rsquo;s a super-active growth key thanks to its R3 tweak!
&amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
Increases protein synthesis, promotes muscle hypertrophy, enhances cell survival, with minor glucose uptake effects (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 boosts protein, bulks muscles, keeps cells alive, and tweaks sugar a bit&amp;mdash;growth magic (Adams et al., 1999)!
&amp;nbsp;SAFETY AND SIDE EFFECTS
Safe at studied doses (up to 1 mg/kg in rats) with no adverse effects reported; minimal systemic impact (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
At lab doses, IGF-1 LR3&amp;rsquo;s chill&amp;mdash;no trouble in rats up to 1 mg/kg (Adams et al., 1999)!
&amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
Subcutaneous injection at 1 mg/mL in acetic acid or bacteriostatic water; typical rat doses 1 mg/kg (Adams et al., 1999). Store at -20&amp;deg;C post-reconstitution.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Inject IGF-1 LR3 under the skin after mixing with acid water&amp;mdash;1 mg/kg for rats rocks it (Adams et al., 1999)! Freeze it at -20&amp;deg;C to keep it fresh!
&amp;nbsp;ADVERSE EFFECTS REPORTED
No significant adverse effects reported; high tolerability up to 1 mg/kg in rats (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
No big oopsies&amp;mdash;rats handle 1 mg/kg like pros (Adams et al., 1999)!
&amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Rat studies show 20&amp;ndash;40% muscle hypertrophy at 1 mg/kg (Adams et al., 1999); in vitro, 2- to 3-fold myoblast proliferation (Florini et al., 1996).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, IGF-1 LR3 bulks muscles 20&amp;ndash;40%, and in dishes, triples cell growth&amp;mdash;science gold (Adams et al., 1999; Florini et al., 1996)!
&amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Limited to preclinical data; no human studies, small sample sizes, long-term effects uncharted (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Only animal tales&amp;mdash;no human scoop, tiny test groups, and long-term mysteries (Adams et al., 1999)!
&amp;nbsp;RESEARCH BASED OBSERVATIONS
Enhances muscle growth, supports neuronal survival, with hypothesized metabolic benefits (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
IGF-1 LR3 pumps muscles, shields brain cells, and might tweak body fuel&amp;mdash;cool guesses (Adams et al., 1999)!
&amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro: 2- to 3-fold myoblast growth (Florini et al., 1996); in vivo: 20&amp;ndash;40% muscle increase (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In dishes, triples muscle cells; in rats, bulks muscles 20&amp;ndash;40%&amp;mdash;lab fireworks (Florini et al., 1996; Adams et al., 1999)!
&amp;nbsp;TYPICAL DOSES USED IN RESEARCH
1 mg/kg in rats (Adams et al., 1999); 0.5 mg/kg in mice (Philippou et al., 2007).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rat doses at 1 mg/kg, mice at 0.5 mg/kg&amp;mdash;tiny growth shots (Adams et al., 1999; Philippou et al., 2007)!
&amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term safety, human efficacy, systemic impacts need exploration (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
What happens years later? How&amp;rsquo;s it in people or body-wide? Big questions (Adams et al., 1999)!
&amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
Targets IGF-1R, upregulates mTOR via PI3K/Akt, reduces IGFBP binding (Adams et al., 1999).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Hits IGF-1R, cranks mTOR with PI3K/Akt, dodges binding traps&amp;mdash;growth wizardry (Adams et al., 1999)!
&amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Synergy with exercise, neurotherapies, or anabolic agents (Adams et al., 1999).
&amp;nbsp;

">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/igf-lr3-gradient.jpg">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./IGF-1 LR3 - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./IGF-1 LR3 - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./IGF-1 LR3 - Peptide Standard_files/css(1)" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button (↻) to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./IGF-1 LR3 - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="https://peptidestandard.com/">
          <img class="header-logo-image visible" src="./IGF-1 LR3 - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/igf1-lr3/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/igf1-lr3/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/igf1-lr3/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/igf1-lr3/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        IGF-1 LR3
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="https://peptidestandard.com/"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/igf1-lr3/"><span>IGF-1 LR3</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<p><img src="./IGF-1 LR3 - Peptide Standard_files/igf-lr3-gradient.jpg" width="500" height="500" alt=""></p>
<p>Molecular Formula - C13H11N5O3</p>
<p>Molecular Weight - 285.26 u</p>
<p>Research Category - Muscle Developmentm Research</p>
<p>Purity - 99.99%</p>
<p>Lab Tested - Yes</p>
<p><iframe src="./IGF-1 LR3 - Peptide Standard_files/saved_resource.html" width="320" height="240" frameborder="0"></iframe></p>
<h1>FULL CHEMICAL NAME</h1>
<p>Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic recombinant analog of human IGF-1, a 70-amino-acid polypeptide hormone with an extended 13-amino-acid substitution at the N-terminus (MFPAMPLSSLFVN) replacing the natural glutamic acid at position 3 (E3R mutation). Its full chemical name reflects this sequence: Methionyl-Phenylalanyl-Prolyl-Alanyl-Methionyl-Prolyl-Leucyl-Serine-Serine-Leucyl-Phenylalanyl-Valine-Asnyl-IGF-1 (E3R), designed to enhance stability and bioactivity by reducing binding affinity to IGF-binding proteins (IGFBPs), thereby prolonging its half-life in research applications compared to native IGF-1.</p>
<h1>&nbsp;ALIASES</h1>
<p>Yes, IGF-1 LR3 is commonly referred to as Long R3 IGF-1, highlighting its extended arginine-substituted (R3) structure. Other aliases include IGF-1 Long Arg3, LR3-IGF-1, or simply Long IGF-1 in research literature, emphasizing its modification for prolonged activity. The E3R designation specifically denotes the glutamic acid-to-arginine substitution at position 3, distinguishing it from native IGF-1 or other analogs like mechano-growth factor (MGF), though these terms are consistently tied to its synthetic origin.</p>
<h1>&nbsp;EMERGING TRENDS IN RESEARCH</h1>
<p>Emerging trends in IGF-1 LR3 research focus on its potential in regenerative medicine, hypothesizing enhanced muscle repair and hypertrophy due to its prolonged anabolic signaling via the IGF-1 receptor (IGF-1R). Studies explore its neuroprotective effects in models of neuronal injury, suggesting it may mitigate cell loss or promote axonal growth through PI3K/Akt pathways. Additionally, there’s interest in its role in metabolic regulation, with speculation about modulating insulin sensitivity or combating sarcopenia in aging models, though these applications remain preclinical and require rigorous validation to substantiate efficacy and safety.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Scientists are pumped about IGF-1 LR3—it might be a game-changer for fixing muscles or even shielding brain cells after damage! They’re guessing it could boost strength, help with aging muscle loss, or tweak sugar use in the body—like a supercharged growth helper with big possibilities still being tested!</p>
<h1>&nbsp;NOTABLE INTERACTIONS</h1>
<p>IGF-1 LR3 binds primarily to the IGF-1 receptor (IGF-1R), a tyrosine kinase receptor, activating PI3K/Akt and MAPK/ERK pathways to promote cell proliferation and survival. Unlike native IGF-1, its reduced affinity for IGFBPs (e.g., IGFBP-3) extends its bioavailability, amplifying interactions with downstream effectors like mTOR. It shares functional overlap with insulin via cross-reactivity with the insulin receptor (IR) at high concentrations, potentially influencing glucose uptake, though this is less pronounced. No significant interactions with non-anabolic systems (e.g., immune or cardiovascular) are well-documented, but its systemic effects via IGF-1R are broad.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 is a VIP at the growth party—it locks onto IGF-1R, sparking signals (PI3K/Akt, MAPK) that tell cells to grow and thrive! It dodges clingy binding proteins to stay active longer, and might flirt with insulin’s receptor for sugar duties—it’s a busy growth maestro in the body!</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>In rat models, IGF-1 LR3 increases muscle fiber cross-sectional area by 20–40% over 2–4 weeks at 1 mg/kg/day (Adams et al., 1999). In vitro, it enhances myoblast proliferation by 2- to 3-fold compared to controls (Florini et al., 1996). No direct IGF-1 level increase occurs, as it is an IGF-1 analog, but its prolonged activity amplifies anabolic effects compared to native IGF-1, with studies showing 2–3 times greater potency in protein synthesis assays.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In lab rats, IGF-1 LR3 bulks muscle fibers 20–40% in weeks with a 1 mg/kg shot daily (Adams et al., 1999)! In dishes, it doubles or triples muscle cell growth—it’s like nitro fuel for building strength, way stronger than regular IGF-1!</p>
<h1>&nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>IGF-1 LR3 is designated for research use only, with standard warnings: ‘Not for human consumption,’ ‘For laboratory use only,’ and requiring IRB/IACUC oversight. No specific contraindications beyond these are noted in preclinical literature, as toxicity data is minimal at studied doses. Its potent anabolic effects warrant careful handling in controlled settings, but no evidence-based bans apply beyond regulatory restrictions.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 is a lab-only rockstar—labeled ‘No humans allowed!’ and meant for science, not people. It’s got the usual research rules, but no big danger signs—it’s safe for study if you play by the book!</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>Reconstitute IGF-1 LR3 in sterile acetic acid (0.6%) or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure solubility and stability. Store lyophilized powder at 2–8°C and reconstituted solution at -20°C, avoiding freeze-thaw cycles to preserve bioactivity. Use within 4 weeks post-reconstitution, and handle with low-protein-binding materials to prevent adsorption losses.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Mix IGF-1 LR3 with a tiny bit of acid water or special water to make a 1 mg/mL potion—keep it germ-free! Store the dry stuff in the fridge, freeze the mix at -20°C like a growth popsicle, and use it within a month—gentle handling keeps its power strong!</p>
<h1>&nbsp;CLINICAL TRIALS AND HUMAN RESEARCH</h1>
<p>No clinical trials or human research exist for IGF-1 LR3 as of February 2025; its evaluation is limited to preclinical animal models (e.g., rats, mice) and in vitro studies. Native IGF-1 has clinical applications, but LR3’s modifications restrict it to research due to insufficient safety data for human use.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 is all animal labs—no human chapters yet! It’s wowed rats and dishes, but unlike regular IGF-1, it’s not ready for people—still needs more safety homework!</p>
<h1>&nbsp;EFFECTS ON DIFFERENT TISSUE TYPES</h1>
<p>IGF-1 LR3 primarily affects skeletal muscle, promoting hypertrophy and regeneration via IGF-1R-mediated protein synthesis. It also influences neuronal tissue, enhancing survival in cell models, and minimally impacts liver or adipose tissue beyond systemic IGF-1R signaling (Adams et al., 1999). No significant effects on non-target tissues like heart or kidney are noted in preclinical studies.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 is a muscle and brain booster—it bulks up muscles and might protect nerve cells, thanks to its growth receptor (Adams et al., 1999)! It mostly skips other spots like heart or fat—it’s a targeted growth wizard!</p>
<h1>&nbsp;EFFICACY IN ANIMAL MODELS</h1>
<p>In rats, IGF-1 LR3 (1 mg/kg/day) increases muscle mass by 20–40% over 2 weeks (Adams et al., 1999). In mice, it enhances satellite cell activation by 50% at 0.5 mg/kg, supporting repair (Philippou et al., 2007), showcasing potent anabolic efficacy.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In rats, IGF-1 LR3 pumps muscle 20–40% bigger in weeks (Adams et al., 1999), and in mice, it revs repair cells 50%—it’s a lab strength superhero!</p>
<h1>&nbsp;FUTURE RESEARCH</h1>
<p>Future IGF-1 LR3 research may explore its role in muscle-wasting diseases, neuroprotection for neurodegenerative conditions, or synergy with regenerative therapies.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>What’s next for IGF-1 LR3? Maybe fixing weak muscles, guarding brains, or teaming up with repair boosters—it’s got a big future to chase!</p>
<h1>&nbsp;HISTORY OF MODELS TESTED</h1>
<p>Tested in rat and mouse models (e.g., muscle hypertrophy studies) and in vitro myoblast and neuronal cultures; no human trials reported (Adams et al., 1999; Philippou et al., 2007).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3’s been a hit in rats, mice, and lab dishes—bulking muscles and shielding cells—but no human spotlight yet (Adams et al., 1999; Philippou et al., 2007)!</p>
<h1>&nbsp;TOXICITY DATA AVAILABLE</h1>
<p>No formal LD50 data exists; studies report no toxicity at doses up to 1 mg/kg in rats, with no organ damage observed (Adams et al., 1999). High tolerability noted.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>No ‘danger limit’ yet—rats take 1 mg/kg like champs with no harm (Adams et al., 1999)! It’s a safety star so far!</p>
<h1>&nbsp;MECHANISM OF ACTION</h1>
<p>IGF-1 LR3 binds IGF-1R, activating PI3K/Akt and MAPK/ERK pathways, upregulating protein synthesis via mTOR and inhibiting apoptosis. Its E3R modification reduces IGFBP binding, enhancing bioavailability.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 locks onto IGF-1R, flipping growth switches (PI3K/Akt, MAPK) to build proteins via mTOR and block cell death—it’s a super-active growth key thanks to its R3 tweak!</p>
<h1>&nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS</h1>
<p>Increases protein synthesis, promotes muscle hypertrophy, enhances cell survival, with minor glucose uptake effects (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 boosts protein, bulks muscles, keeps cells alive, and tweaks sugar a bit—growth magic (Adams et al., 1999)!</p>
<h1>&nbsp;SAFETY AND SIDE EFFECTS</h1>
<p>Safe at studied doses (up to 1 mg/kg in rats) with no adverse effects reported; minimal systemic impact (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>At lab doses, IGF-1 LR3’s chill—no trouble in rats up to 1 mg/kg (Adams et al., 1999)!</p>
<h1>&nbsp;ADMINISTRATION METHODS RECOMMENDED</h1>
<p>Subcutaneous injection at 1 mg/mL in acetic acid or bacteriostatic water; typical rat doses 1 mg/kg (Adams et al., 1999). Store at -20°C post-reconstitution.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Inject IGF-1 LR3 under the skin after mixing with acid water—1 mg/kg for rats rocks it (Adams et al., 1999)! Freeze it at -20°C to keep it fresh!</p>
<h1>&nbsp;ADVERSE EFFECTS REPORTED</h1>
<p>No significant adverse effects reported; high tolerability up to 1 mg/kg in rats (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>No big oopsies—rats handle 1 mg/kg like pros (Adams et al., 1999)!</p>
<h1>&nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</h1>
<p>Rat studies show 20–40% muscle hypertrophy at 1 mg/kg (Adams et al., 1999); in vitro, 2- to 3-fold myoblast proliferation (Florini et al., 1996).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In rats, IGF-1 LR3 bulks muscles 20–40%, and in dishes, triples cell growth—science gold (Adams et al., 1999; Florini et al., 1996)!</p>
<h1>&nbsp;LIMITATIONS OF CURRENT RESEARCH DATA</h1>
<p>Limited to preclinical data; no human studies, small sample sizes, long-term effects uncharted (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Only animal tales—no human scoop, tiny test groups, and long-term mysteries (Adams et al., 1999)!</p>
<h1>&nbsp;RESEARCH BASED OBSERVATIONS</h1>
<p>Enhances muscle growth, supports neuronal survival, with hypothesized metabolic benefits (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>IGF-1 LR3 pumps muscles, shields brain cells, and might tweak body fuel—cool guesses (Adams et al., 1999)!</p>
<h1>&nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</h1>
<p>In vitro: 2- to 3-fold myoblast growth (Florini et al., 1996); in vivo: 20–40% muscle increase (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In dishes, triples muscle cells; in rats, bulks muscles 20–40%—lab fireworks (Florini et al., 1996; Adams et al., 1999)!</p>
<h1>&nbsp;TYPICAL DOSES USED IN RESEARCH</h1>
<p>1 mg/kg in rats (Adams et al., 1999); 0.5 mg/kg in mice (Philippou et al., 2007).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rat doses at 1 mg/kg, mice at 0.5 mg/kg—tiny growth shots (Adams et al., 1999; Philippou et al., 2007)!</p>
<h1>&nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION</h1>
<p>Long-term safety, human efficacy, systemic impacts need exploration (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>What happens years later? How’s it in people or body-wide? Big questions (Adams et al., 1999)!</p>
<h1>&nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</h1>
<p>Targets IGF-1R, upregulates mTOR via PI3K/Akt, reduces IGFBP binding (Adams et al., 1999).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Hits IGF-1R, cranks mTOR with PI3K/Akt, dodges binding traps—growth wizardry (Adams et al., 1999)!</p>
<h1>&nbsp;POTENTIAL RESEARCH EXPLORATIONS</h1>
<p>Synergy with exercise, neurotherapies, or anabolic agents (Adams et al., 1999).</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/igf1-lr3/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=IGF-1%20LR3&amp;body=https://peptidestandard.com/store/igf1-lr3/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/igf1-lr3/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/igf1-lr3/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/igf1-lr3/"},"headline":"IGF-1 LR3","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"IGF-1 LR3"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin β4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/igf1-lr3/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/igf1-lr3/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/igf1-lr3/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/igf1-lr3/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo">© <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="https://peptidestandard.com/">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/igf1-lr3/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/igf1-lr3/","name":"IGF-1 LR3"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./IGF-1 LR3 - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./IGF-1 LR3 - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./IGF-1 LR3 - Peptide Standard_files/collector.js" async=""></script><script src="./IGF-1 LR3 - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./IGF-1 LR3 - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;">✕</div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./IGF-1 LR3 - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./IGF-1 LR3 - Peptide Standard_files/saved_resource(1).html"></iframe></div></body></html>